Write in a clean editor, then format for Oxford Medical Case Reports in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Oxford Medical Case Reports is a peer-reviewed journal published by Oxford University Press, covering Infective Endocarditis Diagnosis and Management, Cardiac Structural Anomalies and Repair, Vasculitis and related conditions.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Oxford Medical Case Reports, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — Oxford Medical Case Reports has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Infective Endocarditis Diagnosis and Management Cardiac Structural Anomalies and Repair Vasculitis and related conditions Infectious Diseases and Tuberculosis Cardiac Arrhythmias and Treatments |
| ISSN | 2053-8855 |
| Citation impact (2-yr) | 0.57 |
| h-index | 23 |
| i10-index | 163 |
| Total citations | 5,968 |
| Article processing charge | $981 |
| Open access | Yes |
| Top institutions publishing here | Latakia University |
| Journal website | academic.oup.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Posterior reversible encephalopathy syndrome (PRES) is a clinico-radiological syndrome characterized by a headache, seizures, altered mental status and visual loss and characterized by white matter vasogenic edema affecting the posterior occipital and parietal lobes of the brain predominantly. This clinical syndrome is increasingly recognized due to improvement and availability of brain imaging specifically magnetic resonance…
Rhabdomyolysis is a well-documented side effect of statin therapy. This risk is increased with concurrent use of medications that inhibit cytochrome p450-3A4 (CYP3A4), such as macrolide antibiotics. We present the case of a 67-year-old patient who was commenced on clarithromycin on a background of simvastatin therapy, resulting in rhabdomyolysis. This case highlights the need for…
Recently, the layering of augmented reality information on top of smartphone applications has created unprecedented user engagement and popularity. One augmented reality-based entertainment application, Pokémon Go (Pokémon Company, Tokyo, Japan) has become the most rapidly downloaded in history. This technology holds tremendous promise to promote ambulatory activity. However, there exists the obvious potential for distraction-related…
Secukinumab is a human monoclonal antibody against IL-17A that has been shown to be effective in psoriasis, psoriatic arthritis and ankylosing spondylitis (AS). On the other hand, in randomized controlled trials among patients with Crohn’s disease (CD) and uveitis due to Behçet’s syndrome (BS) treated with secukinumab, primary end points were not met and the…
Sodium glucose co-transporter (SGLT-2) inhibitor is a relatively new medication used to treat diabetes. At present, the Food and Drug Administration (FDA) has only approved three medications (canagliflozin, dapagliflozin and empagliflozin) in this drug class for the management of Type 2 diabetes. In May 2015, the FDA issued a warning of ketoacidosis with use of…
